Expression and functional role of urotensin-II and its receptor in the adrenal cortex and medulla: Novel insights for the pathophysiology of primary aldosteronism

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 2, 2009, Pages 684-690

  Giuliani, Luisa ^a   Lenzini, Livia ^a   Antonello, Michele ^a   Aldighieri, Enrico ^a   Belloni, Anna S ^a   Fassina, Ambrogio ^a   Gomez Sanchez, Celso ^b,c   Rossi, Gian Paolo ^a,d  

^a UNIVERSITY OF PADOVA   (Italy)

^b G V SONNY MONTGOMERY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; UROTENSIN 2 RECEPTOR; UROTENSIN II;

ADRENAL CORTEX; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

RATTUS;

EID: 59749095699     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1131     Document Type: Article

References (39)

1. Nussdorfer GG 1996 Paracrine control of adrenal cortical function by medullary chromaffin cells. Pharmacol Rev 48:495-530
2. Nussdorfer GG, Rossi GP, Belloni AS 1997 The role of endothelins in the paracrine control of the secretion and growth of the adrenal cortex. [Review] Int Rev Cytol 171:267-308
3. Tal M, Ammar DA, Karpuj M, Krizhanovsky V, Naim M, Thompson DA 1995 A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia. Biochem Biophys Res Commun 209:752-759
4. Maguire JJ, Kuc RE, Davenport AP 2000 Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 131:441-446
5. Douglas SA, Tayara L, Ohlstein EH, Halawa N, Giaid A 2002 Congestive heart failure and expression of myocardial urotensin II. Lancet 359:1990-1997
6. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, McNulty DE, Ellis CE, Elshourbagy NA, Shabon U, Trill JJ, Hay DW, Douglas SA 1999 Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401:282-286
7. Richards AM, Charles C 2004 Urotensin II in the cardiovascular system. Peptides 25:1795-1802
8. Pearson D, Shively JE, Clark BR, Geschwind II, Barkley M, Nishioka RS, Bern HA1980 Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc Natl Acad Sci USA 77:5021-5024
9. Matsushita M, Shichiri M, Imai T, Iwashina M, Tanaka H, Takasu N, Hirata Y 2001 Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J Hypertens 19:2185-2190
10. Kompa AR, Thomas WG, See F, Tzanidis A, Hannan RD, Krum H 2004 Cardiovascular role of urotensin II: effect of chronic infusion in the rat. Peptides 25:1783-1788
11. Conlon JM, Yano K, Waugh D, Hazon N 1996 Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates. J Exp Zool 275:226-238
12. Bern HA, Pearson D, Larson BA, Nishioka RS 1985 Neurohormones from fish tails: the caudal neurosecretory system. I. "Urophysiology" and the caudal neurosecretory system of fishes. Recent Prog Horm Res 41:533-552
13. Takahashi K, Totsune K, Murakami O, Shibahara S 2001 Expression of urotensin II and urotensin II receptor mRNAs in various human tumor cell lines and secretion of urotensin II-like immunoreactivity by SW-13 adrenocortical carcinoma cells. Peptides 22:1175-1179
14. Takahashi K, Totsune K, Murakami O, Arihara Z, Noshiro T, Hayashi Y, Shibahara S 2003 Expression of urotensin II and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin II. Peptides 24:301-306
15. Albertin G, Casale V, Ziolkowska A, Spinazzi R, Malendowicz LK, Rossi GP, Nussdorfer GG 2006 Urotensin-II and UII-receptor expression and function in the rat adrenal cortex. Int J Mol Med 17:1111-1115
16. Zeng ZP, Liu GQ, Li HZ, Fan XR, Liu DM, Tong AL, Zheng X, Liu C 2006 The effects of urotensin-II on proliferation of pheochromocytoma cells and mRNA expression of urotensin-II and its receptor in pheochromocytoma tissues. Ann NY Acad Sci 1073:284-289
17. Grieco P, Carotenuto A, Campiglia P, Marinelli L, Lama T, Patacchini R, Santicioli P, Maggi CA, Rovero P, Novellino E 2005 Urotensin-II receptor ligands. From agonist to antagonist activity. J Med Chem 48:7290-7297
18. Clozel M, Binkert C, Birker-Robaczewska M, Boukhadra C, Ding SS, Fischli W, Hess P, Mathys B, Morrison K, Muller C, Muller C, Nayler O, Qiu C, Rey M, Scherz MW, Velker J, Weller T, Xi JF, Ziltener P 2004 Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin system. J Pharmacol Exp Ther 311:204-212
19. Carotenuto A, Grieco P, Rovero P, Novellino E 2006 Urotensin-II receptor antagonists. Curr Med Chem 13:267-275
20. Rossi G, Albertin G, Belloni A, Zanin L, Biasolo MA, Prayer GT, Bader M, Nussdorfer GG, Palu G, Pessina AC 1994 Gene expression, localization, and characterization of endothelin A and B receptors in the human adrenal cortex. J Clin Invest 94:1226-1234
21. Rossi GP, Sacchetto A, Chiesura-Corona M, DeToni R, Gallina M, Feltrin GP, Pessina AC 2001 Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 86:1083-1090
22. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F 2006 A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48:2293-2300
23. Rossi GP, Pessina AC, Heagerty AM 2008 Primary aldosteronism: an update on screening, diagnosis and treatment. J Hypertens 26:613-621
24. Rossi GP, Seccia TM, Pessina AC 2007 Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension. Crit Rev Clin Lab Sci 44:1-85
25. Rossi GP, Sticchi D, Giuliani L, Bernante P, Zavattiero S, Pessina AC, Nussdorfer GG 2006 Adiponectin receptor expression in the human adrenal cortex and aldosterone-producing adenomas. Int J Mol Med 17:975-980
26. Lenzini L, Seccia TM, Aldighieri E, Belloni AS, Bernante P, Giuliani L, Nussdorfer GG, Pessina AC, Rossi GP 2007 Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis. Hypertension 50:1106-1113
27. Rossi GP, Sacchetto A, Rizzoni D, Bova S, Porteri E, Mazzocchi G, Belloni AS, Bahcelioglu M, Nussdorfer GG, Pessina AC 2000 Blockade of angiotensin II type 1 receptor and not of endothelin receptor prevents hypertension and cardiovascular disease in transgenic (mREN2)27 rats via adrenocortical steroid-independent mechanisms. Arterioscler Thromb Vasc Biol 20:949-956
28. Antonello M, Montemurro D, Bolognesi M, Di Pascoli M, Piva A, Grego F, Sticchi D, Giuliani L, Garbisa S, Rossi GP 2007 Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts. Am J Hypertens 20:1321-1328
29. MacKenzie SM, Clark CJ, Fraser R, Gomez-Sanchez CE, Connell JM, Davies E 2000 Expression of 11β-hydroxylase and aldosterone synthase genes in the rat brain. J Mol Endocrinol 24:321-328
30. Watson AM, May CN 2004 Urotensin II, a novel peptide in central and peripheral cardiovascular control. Peptides 25:1759-1766
31. Morimoto R, Satoh F, Murakami O, Totsune K, Arai Y, Suzuki T, Sasano H, Ito S, Takahashi K 2008 Immunolocalization of urotensin II and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissues. Peptides 29:873-880
32. Wajiki M, Ogawa A, Fukui J, Komiya I, Yamada T, Maruyama Y 1985 Co-existence of aldosteronoma and pheochromocytoma in an adrenal gland. J Surg Oncol 28:75-78
33. Tan GH, Carney JA, Grant CS, Young Jr WF 1996 Coexistence of bilateral adrenal phaeochromocytoma and idiopathic hyperaldosteronism. Clin Endocrinol (Oxf) 44:603-609
34. Kitajima W, Saruta T, Kondo K, Yamada R, Aoki S, Nagakubo I 1975 A case of secondary aldosteronism induced by pheochromocytoma. J Urol 114:141-143
35. Kamba S, Yukawa K, Kato D, Matsumoto M, Tokuoka J, Hayashi Y 1978 A case report of primary aldosteronism combined with pheochromocytoma, struma nodosa and aneurysm of the abdominal aorta. Geka Chiryo 38:491-497
36. Gordon RD, Bachmann AW, Klemm SA, Tunny TJ, Stowasser M, Storie WJ, Rutherford JC 1994 An association of primary aldosteronism and adrenaline-secreting phaeochromocytoma. Clin Exp Pharmacol Physiol 21:219-222
37. Andreis PG, Tortorella C, Ziolkowska A, Spinazzi R, Malendowicz LK, Neri G, Nussdorfer GG 2007 Evidence for a paracrine role of endogenous adrenomedullary galanin in the regulation of glucocorticoid secretion in the rat adrenal gland. Int J Mol Med 19:511-515
38. Gloriam DE, Schioth HB, Fredriksson R 2005 Nine new human Rhodopsin family G-protein coupled receptors: identification, sequence characterisation and evolutionary relationship. Biochim Biophys Acta 1722:235-246
39. Reiprich S, Stolt CC, Schreiner S, Parlato R, Wegner M 2008 SoxE proteins are differentially required in mouse adrenal gland development. Mol Biol Cell 19:1575-1586